Efeito dos óleos essenciais sobre a antracnose in vitro e em frutos de mamoeiro / Effect of essential oils on in vitro anthracnose and in fruits of the papaya plant

RESUMO As doenças pós-colheita do mamão são as principais responsáveis pelas perdas que ocorrem durante esse processo. A antracnose é uma doença causada pelo fungo Colletotrichum gloeosporioides. Esse patógeno tem a capacidade de se estabelecer no fruto imaturo, permanecendo em estado latente até que as condições se tornem favoráveis ao seu desenvolvimento. O presente estudo teve como objetivo determinar o efeito fungistático dos óleos essenciais sobre o fungo C.gloeosporioides. Os experimentos foram realizados no laboratório de Fitossanidade da Universidade Estadual de Mato Grosso do Sul, Unidade Universitária de Cassilândia, foram três etapas, quais sejam: I efeito dos óleos essenciais sobre a germinação de conídios, II- ação in vitro dos óleos sobre micélios fúngicos e III- efeito dos óleos essenciais sobre o fungo em frutos do mamoeiro. Para as três fases o delineamento experimental utilizado foi inteiramente casualizado, em esquema fatorial 6 X 5, (óleos essenciais de alecrim, menta, capim-limão, anis, árvore-chá e canela) e cinco concentrações (0 μL, 10 μL, 30 μL, 50 μL, 100 μL), com 5 repetições. A germinação de conídios foi afetada drasticamente pelos óleos de menta e árvore-chá. O efeito fungitóxico do óleo de menta foi confirmado nos experimentos subsequentes, nos quais essa substância na concentração de 100 µL inibiu completamente o crescimento micelial invivo e in vitro do fungo C. gloeosporioides. Os óleos de alecrim e árvore-chá também afetam o crescimento micelial in vivo e in vitro desse fungo, embora em menor intensidade.

ABSTRACT Post-harvest papaya diseases are primarily responsible for the losses suffered during this process. Anthracnose is a disease caused by the Colletotrichum gloeosporioides fungus. This pathogen has the ability to settle in the immature fruit, remaining dormant until conditions become favorable for its development. The purpose of this study was to determine the fungicidal effect of essential oils on the C. gloeosporioides fungus. The experiments were undertaken in the Plant Health laboratory of the State University of Mato Grosso do Sul, at the University Unit of Cassilandia, where an evaluation was performed in three stages, namely: I) the effect of essential oils on spore germination, II) the in vitro action of oils on mycelium fungi, and III) the effect of essential oils on the fungus in papaya fruit. For the three phases, the experimental design was completely randomized in a 6 x 5 factorial arrangement (essential oils of rosemary, mint, lemongrass, anise, tea tree, and cinnamon) and five concentrations (0 uL, 10 uL, 30 uL, 50 uL, 100 uL) with five replications. The spore germination was drastically affected by the mint and tea tree oils. The fungitoxic effect of peppermint oil was confirmed in subsequent experiments in which this substance at a concentration of 100 uL completely inhibited the mycelial in vivo and in vitro growth of the C. gloeosporioides fungus. The rosemary and tea tree oils also affect the mycelial in vivo and in vitro growth of this fungus, albeit to a lesser degree.

Can FDG-PET/CT predict early response to neoadjuvant chemotherapy in breast cancer?

PURPOSE: Neoadjuvant chemotherapy (NAC) in breast cancer is currently used not only for locally advanced tumors, but also for large operable tumors when breast preservation is considered. It also provides the opportunity to evaluate chemotherapy tumor response. Our aim was to correlate the relative change in the standardized uptake value (SUV) of (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET/CT) with pathologic response after NAC. METHODS: We prospectively evaluated 40 patients with invasive ductal breast carcinomas from February 2010 to December 2011. FDG-PET/CT was performed at baseline and after the second cycle of NAC. All patients underwent surgery after NAC. Pathologic response was evaluated according to Residual Cancer Burden (RCB) index. RESULTS: The mean age was 41.9 years. Median primary tumor size was 6 cm. Pathologic complete response (pCR) was obtained in 12 (30%) patients. The tumor baseline mean maximum SUV (SUV(max)), and after second cycle were: 8.97 (sd.4.3) and 4.07 (sd.3.2), respectively. The relative change (ΔSUV) after the second course of NAC was significantly higher for patients with pCR (-81.58%) when compared to the non-pCR patients (-40.18%) (p = 0.001). The optimal ΔSUV threshold that discriminates between pCR and non-pCR was -71.8% (83.3% sensitivity; 78.5% specificity). Moreover, the optimal ΔSUV threshold to discriminate between NAC responders and non-responders was -59.1% (68% sensitivity; 75.0% specificity). CONCLUSIONS: Our data suggest that the FDG-PET/CT ΔSUV after the second course of NAC can predict pathological response in ductal breast carcinomas, and potentially identify a subgroup of non-responding patients for whom ineffective chemotherapy should be avoided. SYNOPSIS: Breast cancer is the most frequently diagnosed cancer in women. The indications for neoadjuvant chemotherapy are increasing. Early information on chemotherapy response is crucial and methods that predict the therapeutic effectiveness might avoid potentially ineffective chemotherapies in non-responding patients.

Immediate breast reconstruction using autologous skin graft associated with breast implant.

BACKGROUND: Immediate breast reconstruction with skin graft is still little mentioned in the literature. Follow-up studies regarding the technique aspects are particularly scarce. The objective was to detail immediate breast reconstruction using autologous skin graft. METHODS: Patients (n = 49) who underwent mastectomies and autologous immediate breast reconstruction with skin graft associated with a breast implant at A. C. Camargo Hospital (São Paulo, Brazil) between January 2007 and July 2010 were included. Information on clinical data, technique details and clinical outcome were prospectively collected. Following mastectomy, the autologous full-thickness skin graft was obtained through an inframammary fold incision along the contralateral breast in most patients. The skin graft was placed on the surface of the pectoralis major muscle after adjustments to conform to the mastectomy defect. A minimum of 10-month follow-up period was established. RESULTS: Patients' age ranged from 35 to 55 years and all received a silicone gel textured surface implant to obtain the necessary breast mound. The mean surgical time was 45 min, and the mean amount of skin resection was 4.5 cm in the largest diameter. Follow-up ranged from 10 to 35 months (median 23). All patients had silicone-gel textured surface implants to perform the breast mound reconstruction. No complications were observed in 87.8% of reconstructions. Forty-six patients (94%) had no complaints about the donor-site aesthetics. The result was a breast mound with a central ellipse of healed skin graft. Three (6%) poor results were observed. Thirty-six patients (67%) reported the results as good or very good. CONCLUSIONS: Our results lead us to conclude that autologous skin graft provided a reliable option in immediate breast reconstruction to skin-sparing mastectomy defects. The technique accomplished a single-stage implant breast reconstruction when there is inadequate skin coverage.

Biphasic systemic anaphylaxis: an inpatient and outpatient study.

We attempted to ascertain the incidence of systemic biphasic anaphylactic reactions in both outpatients and inpatients. Madigan Army Medical Center is a large teaching facility. The Allergy Clinic staff sees approximately 20,000 patients per year, and an average of 27,000 allergy immunotherapy injections are administered each year. During the years 1988 to 1991 we collected data from a total of 35 patients who had experienced, during the 30-minute waiting period in the clinic, symptoms and signs consistent with anaphylaxis. A total of 44 anaphylactic reactions were noted, with only two (5%) involving a biphasic systemic pattern. All patients were observed and treated within the clinic until symptoms and signs had resolved. None of the patients were treated with or were presently using glucocorticosteroids during the time of their reactions. Of the reactions noted, 25 (57%) involved only cutaneous manifestations of anaphylaxis, three (7%) involved the laryngeal/upper airway area, eight (18%) involved bronchospasm alone, three (7%) involved the rhinoconjunctivae, and five (11%) involved more than one site or type. None of the patients experienced any symptoms or signs of cardiovascular compromise or collapse after allergy extract injections. During the years 1986 to 1992 a total of 59 patients were admitted to the medical ward or intensive care unit with the diagnosis of systemic anaphylaxis. Of 59 patients, four (7%) experienced a recurrent (biphasic) anaphylactic reaction without reexposure to the initial inciting agent. The remaining 55 patients (93%) did not experience any further systemic anaphylaxis after initial hospital admission and treatment. Two of the patients with biphasic anaphylaxis were first seen with hypotension and generalized urticaria.(ABSTRACT TRUNCATED AT 250 WORDS)

Cardiovascular effects of pseudoephedrine in medically controlled hypertensive patients.

BACKGROUND: Oral sympathomimetics are effective in the treatment of nasal congestion through stimulation of alpha-adrenergic receptors in the blood vessels of the nasal mucosa. This vasoconstrictor activity has resulted in the general recommendation that such pressor amines not be used in patients with hypertension. No prospective studies have examined the safety of sustained-release pseudoephedrine in hypertensive patients. METHODS: Volunteers (N = 28) with controlled hypertension participated in a randomized, double-blind, placebo-controlled, crossover study that examined the cardiovascular effects of 120 mg of sustained-release pseudoephedrine taken on a twice daily basis. Physician-investigators measured blood pressure and heart rate using mercurial sphygmomanometers during acute and steady-state phases. Compliance was verified with pill counts and serum drug levels. Symptom questionnaires were completed by the volunteers. RESULTS: While a strong statistical correlation was found over time, with minimal increases in mean arterial pressure and heart rate, pseudoephedrine administration did not result in statistically significant changes in any cardiovascular parameter. Mild disturbances in sleeping pattern and urinary retention in some male subjects were the only significant symptoms detected. CONCLUSIONS: We conclude that while sustained-release pseudoephedrine appears safe for the majority of medically controlled hypertensive patients without statistically significant effects on blood pressure or heart rate our studies did show an upward trend in these parameters which, in a larger population of hypertensive patients, may prove to be clinically significant.

Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study.

To test our previous observation that methotrexate reduces corticosteroid requirements of patients with severe asthma, we studied 14 patients with corticosteroid-dependent bronchial asthma in a 24-week randomized double-blind crossover trial comparing a low dosage of methotrexate (15 mg per week) with placebo. At base line the mean dosage of prednisone was 173.5 mg per week (range, 70 to 420). On the average, 36.5 percent less prednisone was required when patients received methotrexate than when they received placebo (P = 0.01). Measurement of forced vital capacity and forced expiratory volume in one second showed that there was no deterioration in the condition of patients in whom the dosage of prednisone was reduced. The patients' subjective assessment of breathing ability indicated significant improvement (P = 0.01). The adverse effects of methotrexate were limited to transient nausea in three patients and an evanescent rash in one patient. Nine patients are still receiving methotrexate 3 to 10 months after the study's conclusion. The dosages of steroids have been further reduced in each of these patients, and prednisone has been discontinued in four. We conclude from this preliminary study that the use of methotrexate allows a significant reduction in the use of corticosteroids in patients with severe asthma without deterioration of pulmonary function.

The effect of troleandomycin and methylprednisolone alone and in combination on bronchial sensitivity to methacholine.

The effect singly and in combination of methylprednisolone and troleandomycin (TAO) on methacholine sensitivity was studied in eight mildly asthmatic patients who did not require regular bronchodilator therapy. Neither drug alone nor in combination significantly altered the bronchial reactivity to methacholine.